Department of Cardiology, Helmsley Electrophysiology Center, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
J Cardiovasc Electrophysiol. 2022 Feb;33(2):308-314. doi: 10.1111/jce.15303. Epub 2021 Dec 9.
Increasing interest in physiological pacing has been countered with challenges such as accurate lead deployment and increasing pacing thresholds with His-bundle pacing (HBP). More recently, left bundle branch area pacing (LBBAP) has emerged as an alternative approach to physiologic pacing.
To compare procedural outcomes and pacing parameters at follow-up during initial adoption of HBP and LBBAP at a single center.
Retrospective review, from September 2016 to January 2020, identified the first 50 patients each who underwent successful HBP or LBBAP. Pacing parameters were then assessed at first follow-up after implantation and after approximately 1 year, evaluating for acceptable pacing parameters defined as sensing R-wave amplitude >5 mV, threshold <2.5 V @ 0.5 ms, and impedance between 400 and 1200 Ω.
The HBP group was younger with lower ejection fraction compared to LBBAP (73.2 ± 15.3 vs. 78.2 ± 9.2 years, p = .047; 51.0 ± 15.9% vs. 57.0 ± 13.1%, p = .044). Post-procedural QRS widths were similarly narrow (119.8 ± 21.2 vs. 116.7 ± 15.2 ms; p = .443) in both groups. Significantly fewer patients with HBP met the outcome for acceptable pacing parameters at initial follow-up (56.0% vs. 96.4%, p = .001) and most recent follow-up (60.7% vs. 94.9%, p ≤ .001; at 399 ± 259 vs. 228 ± 124 days, p ≤ .001). More HBP patients required lead revision due to early battery depletion or concern for pacing failure (0% vs. 13.3%, at a mean of 664 days).
During initial adoption, HBP is associated with a significantly higher frequency of unacceptable pacing parameters, energy consumption, and lead revisions compared with LBBAP.
随着对生理起搏的兴趣日益增加,人们面临着诸如准确放置导联和希氏束起搏(HBP)时起搏阈值增加等挑战。最近,左束支区域起搏(LBBAP)已成为一种替代生理性起搏的方法。
比较单中心首例 HBP 和 LBBAP 患者的手术结果和随访时的起搏参数。
回顾性分析 2016 年 9 月至 2020 年 1 月期间首次成功接受 HBP 或 LBBAP 的 50 例患者。然后在植入后的首次随访和大约 1 年后评估起搏参数,评估标准为可接受的起搏参数,包括感知 R 波振幅>5mV、阈值<2.5V@0.5ms 和阻抗在 400 和 1200Ω 之间。
与 LBBAP 组相比,HBP 组患者年龄更小,射血分数更低(73.2±15.3 岁 vs. 78.2±9.2 岁,p=0.047;51.0±15.9% vs. 57.0±13.1%,p=0.044)。两组术后 QRS 波宽度相似(119.8±21.2 毫秒 vs. 116.7±15.2 毫秒;p=0.443)。HBP 组在首次随访时满足可接受起搏参数的患者比例明显较低(56.0% vs. 96.4%,p=0.001)和最近一次随访时(60.7% vs. 94.9%,p≤0.001;在 399±259 天 vs. 228±124 天,p≤0.001)。由于早期电池耗尽或担心起搏失败,HBP 组需要更换导丝的患者比例明显更高(0% vs. 13.3%,平均时间为 664 天)。
在初始应用中,与 LBBAP 相比,HBP 与不可接受的起搏参数、能量消耗和导丝修订的频率显著更高。